Brad Webb
Foot & Ankle Surgery · Cedar City, UTNPI 1518900562
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,452 of the $3,545 with a category attached, or 69.2%. Stryker accounts for 88.6% of it on its own, with 14 other manufacturers making up the rest. That places this record below the midpoint for foot & ankle surgery clinicians in UT, where the typical reported total is $3,480.
Across 47 payments — averaging $75.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Smith+Nephew$131
- Abbott$55
- Paragon 28, Inc.$36
- Solventum Corporation$26
- Misonix Inc$24
- plus $133 from 9 others
What the payments were for
- Travel & lodging$2,45269%
- Food & beverage$1,09431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 28 | $3,141 |
| Smith+Nephew | 4 | $131 |
| Abbott | 1 | $55 |
| Paragon 28, Inc. | 2 | $36 |
| Solventum Corporation | 1 | $26 |
| Misonix Inc | 1 | $24 |
| Merck | 2 | $23 |
| Nevro Corp. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $17 |
| AbbVie | 1 | $15 |
| Podimetrics, Inc. | 1 | $14 |
| Convatec Inc. | 1 | $12 |
| Boston Scientific | 1 | $12 |
| Integra Lifesciences Corporation | 1 | $11 |
| Organogenesis Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,545 in reported general payments places this provider in the 50th percentile of 104 foot & ankle surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 12 | $13,617 |
| ErtapenemErtapenem Sodium | 22 | $8,348 |
| Linezolid | 26 | $5,679 |
| SantylCollagenase Clostridium Hist. | 16 | $4,847 |
| Cephalexin | 101 | $999 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 22 | $609 |
| Gabapentin | 68 | $579 |
| Terbinafine Hcl | 17 | $441 |
| Cefazolin Sodium | 17 | $388 |
| Mupirocin | 16 | $359 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $327 |
| Diclofenac Sodium | 13 | $304 |
| Doxycycline Monohydrate | 25 | $272 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 42 | $270 |
| Silver Sulfadiazine | 26 | $236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $131 | $4,84716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 104 foot & ankle surgery providers in Utah.
Other foot & ankle surgery in Cedar City
- Gregory AndersonSalt Lake City$1.6M
- Ryan RigbyLogan$975K
- Florian NickischSalt Lake City$474K
- Brian LiljenquistSalt Lake City$263K
- Douglas TooleSalt Lake City$258K
- Francis ClarkWest Jordan$125K
- David SeegmillerSalt Lake City$120K
- Scott ClarkWest Jordan$74K
- Riley RamptonProvidence$49K
- Gregory CookLogan$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.